{
  "name": "Isofol Medical",
  "slug": "isofol-medical",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T04:32:03Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 0.826, volym 197701",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/isofol-medical/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-19",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport för januari - mars 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b6f9817b15cde8964f1a5dd8453f6d48c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a94a051544e5822f96cb831b364dd2210",
            "date": "2026-05-19",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "20260519_Isofol_Delarsrapport_Q1_2026.pdf",
            "text_chars": 32659,
            "sha256": "8c49180568c15e5e7877b572a17d0364cab49ba2ad7049d4e7b71a3f1b1d3b10",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 32659
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-04-10",
        "title": "Årsredovisning 2025",
        "original_title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b98dbde6b06b5d0efdc8c3d81d7a88e80&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a12d1436b8ef91ab5341635badeada46e",
            "date": "2026-04-10",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "Isofol_Arsredovisning_2025.pdf",
            "text_chars": 204995,
            "sha256": "0351fd620637e1c5f22e2296336fbf47aee355388520cb2602a261753c946c62",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 179969
              },
              {
                "number": 2,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 25024
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-18",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Isofol Medical AB (publ) publicerar bokslutskommuniké för januari - december 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bcb52f5e9484e4437e294fa92a6b4134a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/af4cd051abbbf1d79adb663dada035623",
            "date": "2026-02-18",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "20260218_Isofol_Bokslutskommunike_2025.pdf",
            "text_chars": 39927,
            "sha256": "40278a6b5ac5a547ff31897a2157db338fbad145ce8cad5e37114abdcf08ef68",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 39927
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-11-12",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b10ba296260d1545805e08ae4b5788782&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a627cf23052d77b8a20661a77b753e194",
            "date": "2025-11-12",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "20251112_Isofol_Delarsrapport_Q3_2025.pdf",
            "text_chars": 43451,
            "sha256": "7f28877a00d64ee1f5f48a195642bc8f59665c7b40e20049568be9d0f87c1a45",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 43451
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-08-26",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-juni 2025",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1dcd913336ef01255e44309815debcf4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ab5bbf6f23332371e4710057719a0e648",
            "date": "2025-08-26",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "20250826_Isofol_Delarsrapport_Q2_2025.pdf",
            "text_chars": 39006,
            "sha256": "e381dab161da96be93503865cb56f5333a2d89e9eacbdf4de61813bbac6f1da8",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 39006
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-05-21",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari - mars 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b72c901e4dcb7192ebe7c920bcbb5b9ac&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4e3094058e35d8dddd58ce6aae6499c3",
            "date": "2025-05-21",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "20250521_Isofol_Delarsrapport_Q1_2025_final.pdf",
            "text_chars": 33965,
            "sha256": "1c80379a14ac40e1ad27d4eaa65eb457479124a8b6dd7d041de5f73f9e41600b",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 33965
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-04-11",
        "title": "Årsredovisning 2024",
        "original_title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b951c15b6ca77e7887c314196c1fcace6&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aba6d73344c5e9bd4360f6fa6734d66ef",
            "date": "2025-04-11",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "Isofol_Arsredovisning_2024.pdf",
            "text_chars": 201784,
            "sha256": "f97cd8c3aa77ec1729fac9f7530958ddc93b3fedad93f133d43534becb3e0885",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 177507
              },
              {
                "number": 2,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 24275
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-19",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Isofol Medical AB (publ) publicerar bokslutskommuniké, januari - december 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb29c95495e537109a294fb7908c5a727&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad98d022eeb2b9b89d9881402e4e933b1",
            "date": "2025-02-19",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "20250219_Isofol_Bokslutskommunike_2024.pdf",
            "text_chars": 39667,
            "sha256": "0b823cc1c1e63134b2d5985766e994d3c8cfc52863f8bd33fbc5ebd6559a2024",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 39667
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-11-12",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b5c2e34493ddf0a17b69df52bdfcb831a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad8adca4674ca0d2a4db155a9e8a7a450",
            "date": "2024-11-12",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf",
            "text_chars": 40325,
            "sha256": "7a278edff0fc15b3d6137ba72239576aca8730ef77af21e416ce9a318a5c1b45",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 40325
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-08-21",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Isofol Medical AB (publ) publicerar halvårsrapport, januari - juni 2024",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1ee0bc43915515d943d87dd42b03feb9&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7d48a6679628680da42340de12ba69d7",
            "date": "2024-08-21",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf",
            "text_chars": 37391,
            "sha256": "c940e5a941818b110d8ccd64b5a29da94883b6130020954dce84b423fc63c5cf",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 37391
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-05-08",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari - mars 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf9432577248fe06f48f9fe5b9614d490&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/af85082cf68e17b2feb31a3a697929511",
            "date": "2024-05-08",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf",
            "text_chars": 33336,
            "sha256": "bfdda2573b40bfb0b225aa2c112c05c96e0a19fdc8bd7db148383f6050795c0e",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 33336
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-16",
        "title": "Årsredovisning 2023",
        "original_title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=baed8d8983d3af33a8397b6b7d06ec34f&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa820e256acac7ccab25d41c37090757d",
            "date": "2024-04-16",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "Isofol_Arsredovisning_2023_final.pdf",
            "text_chars": 186610,
            "sha256": "621cd17ddbea35b77a8fefc759e64201c1378cd4f97ae69af188625f52803fb7",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 179498
              },
              {
                "number": 2,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 7110
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-20",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Isofol Medical AB (publ) publicerar bokslutskommuniké, januari - december 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bdcca71bdc78ab8214e4b87fbf6949936&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7602ef9b2b257549a8fe1bd4fe653349",
            "date": "2024-02-20",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "02191521.pdf",
            "text_chars": 39153,
            "sha256": "581a8e083b965bd9df8697fb5b1f1c9473150ca029bbf9f537e828bdf91f5191",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 39153
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-11-10",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b43e48f4a0b8b3b0dd647378a5116ddd1&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a1aebb2df992cfd76ff2c5291a77df6c8",
            "date": "2023-11-10",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "11092219.pdf",
            "text_chars": 48615,
            "sha256": "5f5a0f6ce2caf510301dd75dcdedd98b8b59b786c1ecbaa64b194f3c234530a6",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 48615
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-08-22",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Isofol Medical AB (publ) publicerar halvårsrapport, januari-juni 2023",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b74d12a04055165f4cf583d3335fa8462&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a9e9f689ce594cebf31181362f4489de2",
            "date": "2023-08-22",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf",
            "text_chars": 48576,
            "sha256": "dfc41859f861523d002b9d4fc5bbfa568547f4828e8ee60412b2670d8292398d",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 48576
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-05-03",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-mars 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb514f30c1fbf5b05cd70b4c6704281f9&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/acccded929db5e3f2c6b18045e5036e33",
            "date": "2023-05-03",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf",
            "text_chars": 43718,
            "sha256": "e3d6476b33400d7e168c5e7e0964756cc0dc5a1b2ae984a1afc9267d0f4cabfe",
            "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 43718
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Isofol Medical",
    "identity": {
      "issuer": "Sedana Medical AB (publ)",
      "lei": "549300FQ3NJRI56LCX32",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 12,
      "score": 50.0,
      "status": "resolved",
      "requested_company": "Isofol Medical",
      "query": "Sedana Medical AB (publ)",
      "candidate_count": 345
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T04:32:03Z",
    "insider": {
      "transactions": 11,
      "all_export_rows": 11,
      "acquisitions": 8,
      "disposals": 3,
      "other": 0,
      "acquisition_value_sek": 3813095.46,
      "disposal_value_sek": 1808131.55,
      "characters": {
        "Avyttring": 3,
        "Förvärv": 8
      }
    },
    "short_selling": {
      "aggregate_percent": 2.26,
      "current_public_positions": 1,
      "historical_changes": 35,
      "current_position_sum_over_0_5": 0.8
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX2339902",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/isofol?id=TX2339902"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Isofol Medical AB (publ)",
      "expected_name": "Isofol Medical",
      "match_score": 100.0,
      "slug": "isofol-medical",
      "url": "https://mfn.se/all/a/isofol-medical",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://isofolmedical.com/sv/"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX2339902",
      "asset_class": "SHARES",
      "isin": "SE0009581051",
      "symbol": "ISOFOL",
      "company": "Isofol Medical",
      "market": null,
      "last_sale_price": "SEK 0.826",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Sedana Medical AB (publ)",
      "lei": "549300FQ3NJRI56LCX32",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 12,
      "score": 50.0,
      "status": "resolved",
      "requested_company": "Isofol Medical",
      "query": "Sedana Medical AB (publ)",
      "candidate_count": 345
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a94a051544e5822f96cb831b364dd2210",
      "date": "2026-05-19",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "20260519_Isofol_Delarsrapport_Q1_2026.pdf",
      "text_chars": 32659,
      "sha256": "8c49180568c15e5e7877b572a17d0364cab49ba2ad7049d4e7b71a3f1b1d3b10",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 32659
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a12d1436b8ef91ab5341635badeada46e",
      "date": "2026-04-10",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "Isofol_Arsredovisning_2025.pdf",
      "text_chars": 204995,
      "sha256": "0351fd620637e1c5f22e2296336fbf47aee355388520cb2602a261753c946c62",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 179969
        },
        {
          "number": 2,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 25024
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/af4cd051abbbf1d79adb663dada035623",
      "date": "2026-02-18",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "20260218_Isofol_Bokslutskommunike_2025.pdf",
      "text_chars": 39927,
      "sha256": "40278a6b5ac5a547ff31897a2157db338fbad145ce8cad5e37114abdcf08ef68",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 39927
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a627cf23052d77b8a20661a77b753e194",
      "date": "2025-11-12",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "20251112_Isofol_Delarsrapport_Q3_2025.pdf",
      "text_chars": 43451,
      "sha256": "7f28877a00d64ee1f5f48a195642bc8f59665c7b40e20049568be9d0f87c1a45",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 43451
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ab5bbf6f23332371e4710057719a0e648",
      "date": "2025-08-26",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "20250826_Isofol_Delarsrapport_Q2_2025.pdf",
      "text_chars": 39006,
      "sha256": "e381dab161da96be93503865cb56f5333a2d89e9eacbdf4de61813bbac6f1da8",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 39006
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4e3094058e35d8dddd58ce6aae6499c3",
      "date": "2025-05-21",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "20250521_Isofol_Delarsrapport_Q1_2025_final.pdf",
      "text_chars": 33965,
      "sha256": "1c80379a14ac40e1ad27d4eaa65eb457479124a8b6dd7d041de5f73f9e41600b",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 33965
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aba6d73344c5e9bd4360f6fa6734d66ef",
      "date": "2025-04-11",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "Isofol_Arsredovisning_2024.pdf",
      "text_chars": 201784,
      "sha256": "f97cd8c3aa77ec1729fac9f7530958ddc93b3fedad93f133d43534becb3e0885",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 177507
        },
        {
          "number": 2,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 24275
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad98d022eeb2b9b89d9881402e4e933b1",
      "date": "2025-02-19",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "20250219_Isofol_Bokslutskommunike_2024.pdf",
      "text_chars": 39667,
      "sha256": "0b823cc1c1e63134b2d5985766e994d3c8cfc52863f8bd33fbc5ebd6559a2024",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 39667
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad8adca4674ca0d2a4db155a9e8a7a450",
      "date": "2024-11-12",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf",
      "text_chars": 40325,
      "sha256": "7a278edff0fc15b3d6137ba72239576aca8730ef77af21e416ce9a318a5c1b45",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 40325
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7d48a6679628680da42340de12ba69d7",
      "date": "2024-08-21",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf",
      "text_chars": 37391,
      "sha256": "c940e5a941818b110d8ccd64b5a29da94883b6130020954dce84b423fc63c5cf",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 37391
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/af85082cf68e17b2feb31a3a697929511",
      "date": "2024-05-08",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf",
      "text_chars": 33336,
      "sha256": "bfdda2573b40bfb0b225aa2c112c05c96e0a19fdc8bd7db148383f6050795c0e",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 33336
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa820e256acac7ccab25d41c37090757d",
      "date": "2024-04-16",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "Isofol_Arsredovisning_2023_final.pdf",
      "text_chars": 186610,
      "sha256": "621cd17ddbea35b77a8fefc759e64201c1378cd4f97ae69af188625f52803fb7",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 179498
        },
        {
          "number": 2,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 7110
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7602ef9b2b257549a8fe1bd4fe653349",
      "date": "2024-02-20",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "02191521.pdf",
      "text_chars": 39153,
      "sha256": "581a8e083b965bd9df8697fb5b1f1c9473150ca029bbf9f537e828bdf91f5191",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 39153
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a1aebb2df992cfd76ff2c5291a77df6c8",
      "date": "2023-11-10",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "11092219.pdf",
      "text_chars": 48615,
      "sha256": "5f5a0f6ce2caf510301dd75dcdedd98b8b59b786c1ecbaa64b194f3c234530a6",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 48615
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a9e9f689ce594cebf31181362f4489de2",
      "date": "2023-08-22",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf",
      "text_chars": 48576,
      "sha256": "dfc41859f861523d002b9d4fc5bbfa568547f4828e8ee60412b2670d8292398d",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 48576
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/acccded929db5e3f2c6b18045e5036e33",
      "date": "2023-05-03",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf",
      "text_chars": 43718,
      "sha256": "e3d6476b33400d7e168c5e7e0964756cc0dc5a1b2ae984a1afc9267d0f4cabfe",
      "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 43718
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/isofol-medical",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 12822,
      "sha256": "e8aec607a19a90818f8bc3e7e14fd74d47c5fb3b7d32c58ffaf71bdc29f2cfcd",
      "url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/isofol-medical/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 12822
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/isofol-medical/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/isofol-medical/market/history.json",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/isofol-medical/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/isofol-medical/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/isofol-medical/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/isofol-medical/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/isofol-medical/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/isofol-medical/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/isofol-medical/finansinspektionen",
    "transaction_count": 11,
    "aggregate_short_percent": 2.26,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/isofol-medical/llms.txt",
  "json_url": "/company/isofol-medical/company.json",
  "document_index_url": "/company/isofol-medical/documents.json",
  "absolute_url": "https://spela.port0.org/company/isofol-medical"
}